Jodi B Segal
Johns Hopkins University
H-index: 72
North America-United States
Top articles of Jodi B Segal
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA … | bmj | Rishi J Desai Shirley V Wang Sushama Kattinakere Sreedhara Luke Zabotka Farzin Khosrow-Khavar | 2024/2/12 |
Reducing Low-Value Health Care | Annals of Internal Medicine | Jodi B Segal | 2024/2/6 |
Randomized Experiments to Reduce Overuse of Health Care: A Scoping Review | Ravi Gupta Bingrui Emily Xie Meng Zhu Jodi B Segal | 2024/2/5 | |
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study | Allergy | Ayobami Akenroye Guohai Zhou John W Jackson Jodi Segal G Caleb Alexander | 2023/4 |
Comprehensive Diabetes Assessment Instrument for Patients With Type 2 Diabetes | Journal of Primary Care & Community Health | Jodi Segal Robert DeGrazia Jr Samantha Pitts Kristal Brown Maile Taualii | 2023/11 |
Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease | Molecular psychiatry | Vijay R Varma Rishi J Desai Sheeja Navakkode Lik-Wei Wong Carlos Anerillas | 2023/3 |
Patient, provider, and system‐level factors associated with preoperative cardiac testing: A systematic review | Michael I Ellenbogen Aleksandra Drmanovic Jodi B Segal Shrey Kapoor Phillip C Wagner | 2023/11 | |
Switch patterns in a cohort of individuals with asthma who received omalizumab or mepolizumab therapy | The Journal of Allergy and Clinical Immunology: In Practice | Ayobami Akenroye Tessa Ryan Alanna McGill Guohai Zhou Jerome Shier | 2023/3/1 |
Reducing overuse by healthcare systems: a positive deviance analysis | Journal of general internal medicine | Michael I Ellenbogen Aaron A Wiegand J Matthew Austin Nancy L Schoenborn Nihal Kodavarti | 2023/8 |
Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: a target trial emulation | Journal of Allergy and Clinical Immunology | Ayobami T Akenroye Jodi B Segal Guohai Zhou Dinah Foer Lily Li | 2023/5/1 |
Long-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study | Clinical Gastroenterology and Hepatology | Anna S Lok Juhi Moon Kenneth E Sherman Mandana Khalili Dawn Fishbein | 2023/2/1 |
Assessing heterogeneity of treatment effect in real-world data | Annals of internal medicine | Jodi B Segal Ravi Varadhan Rolf HH Groenwold Nicholas C Henderson Xiaojuan Li | 2023/4 |
Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease | Thrombosis research | Shirin Ardeshirrouhanifard Michael I Ellenbogen Jodi B Segal Michael B Streiff Steven B Deitelzweig | 2023/1/1 |
Comparing Different Ways of Asking People with Type 2 Diabetes about Their Care Priorities and Preferences | John FP Bridges Ellen M Janssen Mo Zhou Lee Bone Jodi B Segal | 2023/12/20 | |
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016 | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | Shirin Ardeshirrouhanifard Huijun An Ravi K Goyal Mukaila A Raji Jodi B Segal | 2022/5 |
Development and validation of the summary elixhauser comorbidity score for use with ICD-10-CM–Coded data among older adults | Annals of internal medicine | Hemalkumar B Mehta Shuang Li Huijun An James S Goodwin G Caleb Alexander | 2022/10 |
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among adults with cancer and atrial fibrillation | Clinical and Translational Science | Hye‐Rim Kang Eric A Dietrich Pei‐Lin Huang Wei‐Hsuan Lo‐Ciganic Christina E DeRemer | 2023/6 |
Comparative risk of Alzheimer disease and related dementia among Medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents | JAMA network Open | Rishi J Desai Vijay R Varma Tobias Gerhard Jodi Segal Mufaddal Mahesri | 2022/4/1 |
Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end‐stage kidney disease: A national cohort study | Journal of hospital medicine | Michael I Ellenbogen Shirin Ardeshirrouhanifard Jodi B Segal Michael B Streiff Steven B Deitelzweig | 2022/10 |
Clinical care among individuals with prediabetes in primary care: a retrospective cohort study | Journal of general internal medicine | Eva Tseng Nowella Durkin Jeanne M Clark Nisa M Maruthur Jill A Marsteller | 2022/12 |
